Australia markets closed

Melodiol Global Health Limited (ME1.XA)

Cboe AU - Cboe AU Real-time price. Currency in AUD
Add to watchlist
0.00100.0000 (0.00%)
At close: 01:45PM AEDT

Melodiol Global Health Limited

145 Stirling Highway
Suite 5 CPC
Nedlands, WA 6009
Australia
61 8 9389 3180
https://melodiolglobalhealth.com

Sector(s)
Industry
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Boaz Wachtel M.A., M.D., MBACo-Founder & Non-Executive Chairman80kN/A1961
Mr. William Lay B.Com.Group CEO, MD & Director411.51kN/AN/A
Mr. Christopher Grundy BCom, FCA, FCIS, GAICDChief Financial Officer333.01kN/AN/A
Ms. Micheline MacKay B.Sc., M.Sc., P.M.P.Executive Director237.82kN/AN/A
Dr. Gian TreppCommercial & Marketing DirectorN/AN/AN/A
Mr. Mitchel FlemingManaging Director of HalucenexN/AN/AN/A
Brett AyersManaging Director of ImpactiveN/AN/AN/A
Mr. Winton William Willesee C.P.A., GAICD, MAICD, MComJoint Company SecretaryN/AN/A1970
Hon. Brian WalkerStrategic Consultant & Chair of Scientific Advisory CommitteeN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Melodiol Global Health Limited engages in the development, cultivation, and distribution of recreational and medical cannabis products in Europe, Canada, Australia, and the Asia Pacific. It is involved in the development and commercialisation of nutraceutical products; and medical supplies business. The company was formerly known as Creso Pharma Limited and changed its name to Melodiol Global Health Limited in June 2023. Melodiol Global Health Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.

Corporate governance

Melodiol Global Health Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.